US FDA approves new pill for postpartum depression
The US Food and Drug Administration (FDA) on Friday approved Biogen and Sage Therapeutics’ oral pill to treat postpartum depression (PPD) in adults. The companies had sought the FDA’s approval for the drug, Zurzuvae, to treat major depressive disorder (MDD), or clinical depression, as well as postpartum depression, which affect millions of people. PPD severely […]
Continue Reading